{
  "url": "https://openlegislation.uk/cosmetic-products-restriction-of-chemical-substances-no-2-regulations-2024/schedule-1",
  "json_url": "https://openlegislation.uk/cosmetic-products-restriction-of-chemical-substances-no-2-regulations-2024/schedule-1.json",
  "legislation": "uksi/2024/1334",
  "legislation_title": "The Cosmetic Products (Restriction of Chemical Substances) (No. 2) Regulations 2024",
  "legislation_url": "https://openlegislation.uk/cosmetic-products-restriction-of-chemical-substances-no-2-regulations-2024",
  "path": "schedule/1",
  "kind": "schedule",
  "number": "1",
  "heading": "Amendments to Annex 2",
  "text": "1680\nTetrafluoroethylene\n116-14-3\n204-126-9\n1681\n6,6'-di-tert-butyl-2,2'-methylenedi-p-cresol; [DBMC]\n119-47-1\n204-327-1\n1682\n(5-chloro-2-methoxy-4-methyl-3-pyridyl)(4,5,6-trimethoxy-o-tolyl)methanone; pyriofenone\n688046-61-9\n692-456-8\n1683\n(RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy}ethyl methyl carbonate; tolpyralate\n1101132-67-5\n1684\n3-methylpyrazole\n1453-58-3\n215-925-7\n1685\nN-methoxy-N-[1-methyl-2-(2,4,6-trichlorophenyl)-ethyl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide; Pydiflumetofen\n1228284-64-7\n1686\nN-{2-[[1,1'-bi(cyclopropyl)]-2-yl]phenyl}- 3-(difluoromethyl)-1-methyl-1Hpyrazole-4-carboxamide; Sedaxane\n874967-67-6\n1687\nThiophanate-methyl (ISO); dimethyl (1,2- phenylenedicarbamothioyl)biscarbamat; dimethyl 4,4’-(o-phenylene)bis(3- thioallophanate)\n23564-05-8\n245-740-7\n1688\nMancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt\n8018-01-7\n1689\nTrinickel disulfide; nickel subsulfide; [1] heazlewoodite [2]\n12035-72-2 [1] 12035-71-1 [2]\n234-829-6 [1] – [2]\n1690\n7-oxa-3-oxiranylbicyclo[4.1.0]heptane; 1,2-epoxy-4-epoxyethylcyclohexane; 4-vinylcyclohexene diepoxide\n106-87-6\n203-437-7\n1691\n4-methylpentan-2-one; isobutyl methyl ketone (MIBK)\n108-10-1\n203-550-1\n1692\nCarbendazim (ISO); methyl benzimidazole-2-ylcarbamat\n10605-21-7\n234-232-0\n1693\nDimethomorph (ISO); (E,Z)-4-(3-(4- chlorophenyl)-3-(3,4- dimethoxyphenyl)acryloyl)morpholine\n110488-70-5; (1135441-72-3)\n404-200-2\n1694\n1,2,4-triazole\n288-88-0\n206-022-9\n1695\nFlumioxazin (ISO); N-(7-fluoro-3,4- dihydro-3-oxo-4-prop-2-ynyl-2H-1,4- benzoxazin-6-yl)cyclohex-1-ene-1,2- dicarboximide\n103361-09-7\n1696\nImazamox (ISO); (RS)-2-(4-isopropyl-4- methyl- 5-oxo-2-imidazolin-2-yl)-5- methoxymethylnicotinic acid\n114311-32-9\n1697\nThiamethoxam (ISO); 3-(2-chloro-thiazol-5-ylmethyl)-5- methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine\n153719-23-4\n428-650-4\n1698\nTriticonazole (ISO); (RS)-(E)-5-(4- chlorobenzylidene)-2,2-dimethyl-1-(1H1,2,4-triazol-1-ylmethyl)cyclopentanol\n138182-18-0\n1699\nDesmedipham (ISO); ethyl 3-phenylcarbamoyloxyphenylcarbamate\n13684-56-5\n237-198-5\n1700\nTellurium dioxide\n7446-07-3\n231-193-1\n1701\nTellurium\n13494-80-9\n236-813-4\n1702\nFluopicolide (ISO); 2,6-dichloro-N-[3-chloro-5- (trifluoromethyl)-2- pyridylmethyl]benzamide\n239110-15-7\n607-285-6\n1703\nDaminozide (ISO); 4-(2,2- dimethylhydrazino)-4-oxobutanoic acid; N-dimethylaminosuccinamic acid\n1596-84-5\n216-485-9\n1704\nBenzophenone\n119-61-9\n204-337-6\n1705\nAcetamiprid (ISO); (1E)-N-[(6- chloropyridin-3- yl)methyl]-N'-cyano-N-methylethanimidamide; (E)-N 1 -[(6- chloro-3-pyridyl)methyl]-N 2 -cyano-N 1 – methylacetamidine\n135410-20-7\n603-921-1\n1706\nTheophylline; 1,3-dimethyl-3,7-dihydro-1 H-purine-2,6-dione\n58-55-9\n200-385-7\n1707\nN-(2-nitrophenyl)phosphoric triamide\n874819-71-3\n477-690-9\n1708\nDibutyltin di(acetate)\n1067-33-0\n213-928-8\n1709\nDibutyltin bis(2-ethylhexanoate)\n2781-10-4\n220-481-2\n1710\nCumene\n98-82-8\n202-704-5\n1711\nBarium diboron tetraoxide\n13701-59-2\n237-222-4\n1712\n2-ethyl-2-[[(1-oxoallyl)oxy]methyl]-1,3- propanediyldiacrylate; 2,2- bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylate\n15625-89-5\n239-701-3\n1713\nQuinoclamine (ISO); 2-amino-3-chloro-1,4-naphthoquinone\n2797-51-5\n220-529-2\n1714\nPendimethalin (ISO); N-(1-ethylpropyl)- 2,6-dinitro-3,4-xylidene\n40487-42-1\n254-938-2\n1715\nIsoflucypram (ISO); N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide\n1255734-28-1\n1716\nDimoxystrobin (ISO); (2E)-2-{2-[(2,5- dimethylphenoxy)methyl]phenyl}-2- (methoxyimino)-N-methylacetamide; (E)-2- (methoxyimino)-N-methyl-2-[a-(2,5-xylyloxy)-o-tolyl]acetamide\n149961-52-4\n604-712-8\n1717\n2,2-dimethylpropan-1-ol, tribromo derivative; 3-bromo-2,2- bis(bromomethyl)propan-1-ol\n36483-57-5; 1522-92-5\n253-057-0\n1718\n2,4,6-tri-tert-butylphenol\n732-26-3\n211-989-5\n1719\nAmmonium bromide\n12124-97-9\n235-183-8\n1720\nDivanadium pentaoxide; Vanadium pentoxide\n1314-62-1\n215-239-8\n1721\nBentazone (ISO); 3-isopropyl-2,1,3- benzothiadiazine-4-one-2,2-dioxide\n25057-89-0\n246-585-8\n1722\nMargosa extract. [from the kernels of Azadirachta indica extracted with water and further processed with organic solvents]\n84696-25-3\n283-644-7\n1723\nValifenalate (ISO); methyl N-(isopropoxycarbonyl)-L-valyl- (3RS)-3- (4-chlorophenyl)-β-alaninate\n283159-90-0\n1724\nIsopyrazam (ISO); reaction mass of 3-(difluoromethyl)-1-methyl-N- [(1RS,4SR,9RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4- methanonaphthalen-5-yl]pyrazole-4-carboxamide and 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9SR)-1,2,3,4- tetrahydro-9-isopropyl-1,4-methanonaphthalen-5- yl]pyrazole-4-carboxamide [>78% syn isomers ≤ 15% anti isomers relative content];\n881685-58-1\n1725\nPerfluoroheptanoic acid; tridecafluoroheptanoic acid\n375-85-9\n206-798-9\n1726\n4,4’-sulphonyldiphenol; bisphenol S\n80-09-1\n201-250-5\n1727\n6-[C10-C13)-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid (tetra-PSCA)\n2156592-54-8\n701-118-1\n1728\n6-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid (Penta-PSCA)\n701-162-1\n1729\n[C12-18-alkyl-(branched, unsaturated)- 2,5-dioxopyrrolidin-1-yl] hexanoic acid, sodium and tris(2-hydroxyethyl) ammonium salts; (penta-PSCA Na-TEA)\n701-271-4\n1730\n1,3,5-triazine-2,4,6-triamine; melamine\n108-78-1\n203-615-4\n1731\nBenzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolate\n577705-90-9\n479-100-5\n1732\nBenzyltriphenylphosphonium, salt with 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis[phenol] (1:1)\n75768-65-9\n278-305-5\n1733\nReaction mass of 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolate (1:1)\n1734\nReaction mass of 4,4'-[2,2,2-trifluoro 1-(trifluoromethyl)ethylidene] diphenol and benzyltriphenylphosphonium, salt with 4,4'-[2,2,2-trifluoro-1- (trifluoromethyl)ethylidene]bis[phenol] (1:1)\n1735\nReaction mass of 1-(2,3-epoxypropoxy)-2,2-bis ((2,3-epoxypropoxy)methyl) butane and 1-(2,3-epoxypropoxy)-2- ((2,3-epoxypropoxy)methyl) -2-hydroxymethyl butane\n1736\n4,4'-[2,2,2-trifluoro-1- (trifluoromethyl)ethylidene]diphenol; bisphenol AF\n1478-61-1\n216-036-7\n1737\nTransfluthrin (ISO); 2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate\n118712-89-3\n405-060-5\n1738\nSalts of 2-ethylhexanoic acid\n1739\nBenfluralin (ISO); N-butyl-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine\n1861-40-1\n217-465-2\n1740\nN,N-dimethyl-p-toluidine\n99-97-8\n202-805-4\n1741\n4-nitrosomorpholine\n59-89-2\n1742\n3,3'-dimethylbiphenyl 4,4'-diyl diisocyanate\n91-97-4\n202-112-7\n1743\nForamsulfuron (ISO); 2-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-4-formamido-N,N dimethylbenzamide; 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-dimethylcarbamoyl-5-formamidophenylsulfonyl)urea\n173159-57-4",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2024/1334/schedule/1",
    "retrieved_at": "2026-10-28T21:22:38.234458+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}